Sponsor

VectivBio AG

Aeschenvorstadt 36, 4051

About the sponsor

Research activity includes acute graft versus host disease, with a focus on steroid-refractory gastrointestinal aGVHD affecting the lower digestive tract.

Immune-mediated intestinal injury
Gastrointestinal inflammation
Post-transplant complications

The sponsor’s studies in this area are centered on gastrointestinal symptoms and clinical safety in patients with severe transplant-related bowel involvement.

About Specializations

VectivBio AG runs clinical trials in conditions such as Short-bowel syndrome, Acute graft versus host disease in intestine, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

3 clinical trials

Short-bowel syndrome

Not recruiting

Relative Bioavailability of Apraglutide in Prefilled Syringe versus Vial after Subcutaneous Injection in Healthy Subjects

InvestigationalNo placebo

Relative Bioavailability of Apraglutide in Prefilled Syringe versus Vial after Subcutaneous Injection in Healthy Subjects

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Apraglutide
Sponsor:VectivBio AG

Contact Research Centre

Acute graft versus host disease in intestine

Not recruiting

Study on the Safety and Effectiveness of Apraglutide for Patients with Steroid-Resistant Gastrointestinal Acute Graft Versus Host Disease

InvestigationalNo placebo

Study on the Safety and Effectiveness of Apraglutide for Patients with Steroid-Resistant Gastrointestinal Acute Graft Versus Host Disease

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Apraglutide
Sponsor:VectivBio AG

Contact Research Centre

Short-bowel syndrome

Not recruiting

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

InvestigationalNo placebo

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Apraglutide
Sponsor:VectivBio AG

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

About the sponsor

About Specializations

Ongoing trials

3 clinical trials

Short-bowel syndrome

Relative Bioavailability of Apraglutide in Prefilled Syringe versus Vial after Subcutaneous Injection in Healthy Subjects

Acute graft versus host disease in intestine

Study on the Safety and Effectiveness of Apraglutide for Patients with Steroid-Resistant Gastrointestinal Acute Graft Versus Host Disease

Short-bowel syndrome

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

Are you running a clinical trial?

Prefer not to search? Our Concierge searches the trials for you.